The multicenter, phase III trial, DREAMseq showed a remarkable 20% advantage in the two-year…
Radformation Inc and Videra Surgical are integrating Videra Surgical’s VeraForm…
UTHealth Houston researchers report in JAMA Network Open that US populations more vulnerable…
Research published in The Journal of Nuclear Medicine reports a new PET radiotracer…
The US FDA has accepted Blue Earth Diagnostics’ New Drug Application…
A new multidisciplinary team examining radiation therapy combined with immunotherapy will be…
The MRIdian MRI-Guided Radiation Therapy System from ViewRay has received approval from…
Telix Pharmaceuticals Limited reported the IPAX-1 Phase I/II study of TLX101 therapy (4-L-[…
A joint venture by The University of Texas MD Anderson Cancer Center and Radiopharm…
Earlier this month, the Hadassah Cancer Research Institute (HCRI) at the Hadassah University…
